BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2572822)

  • 1. Intralesional vinblastine for oral Kaposi sarcoma in HIV infection.
    Epstein JB; Scully C
    Lancet; 1989 Nov; 2(8671):1100-1. PubMed ID: 2572822
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
    Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
    Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of oral Kaposi sarcoma with intralesional vinblastine.
    Epstein JB
    Cancer; 1993 Mar; 71(5):1722-5. PubMed ID: 8448735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional vinblastine therapy for Kaposi's sarcoma of the epiglottis.
    Tami TA; Sharma PK
    Otolaryngol Head Neck Surg; 1995 Sep; 113(3):283-5. PubMed ID: 7675491
    [No Abstract]   [Full Text] [Related]  

  • 5. Intralesional vinblastine in the treatment of oral Kaposi's sarcoma.
    Moyle G; Youle M; Barton S
    Br J Clin Pract; 1993; 47(2):79-80. PubMed ID: 8334068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intralesional vinblastine in the treatment of Kaposi's sarcoma. Presentation of a case].
    Gaglioti D; Ficarra G; Nardi P
    Minerva Stomatol; 1989 Sep; 38(9):955-7. PubMed ID: 2811811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.
    McCormick SU
    J Oral Maxillofac Surg; 1996 May; 54(5):583-7; discussion 588-9. PubMed ID: 8632242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
    Flaitz CM; Nichols CM; Hicks MJ
    Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.
    Ramírez-Amador V; Esquivel-Pedraza L; Lozada-Nur F; De la Rosa-García E; Volkow-Fernández P; Súchil-Bernal L; Mohar A
    Oral Oncol; 2002 Jul; 38(5):460-7. PubMed ID: 12110340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kaposi sarcoma in AIDS patients. Treatment with a vinblastine-vincristine and molgramostim combination].
    Dine G; Bressieux JM; Penouil MH; Brahimi S
    Presse Med; 1995 Jun; 24(22):1048. PubMed ID: 7667236
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen.
    Kaplan L; Abrams D; Volberding P
    Cancer Treat Rep; 1986 Sep; 70(9):1121-2. PubMed ID: 3742492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome.
    Volberding PA; Abrams DI; Conant M; Kaslow K; Vranizan K; Ziegler J
    Ann Intern Med; 1985 Sep; 103(3):335-8. PubMed ID: 4026082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caution in the use of local therapies for Kaposi's sarcoma.
    Tappero JW; Berger TG
    Arch Dermatol; 1993 Jan; 129(1):42. PubMed ID: 8420484
    [No Abstract]   [Full Text] [Related]  

  • 14. Treating Kaposi's lesions in the HIV-infected patient.
    Nichols CM; Flaitz CM; Hicks MJ
    J Am Dent Assoc; 1993 Nov; 124(11):78-84. PubMed ID: 8227776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raynaud phenomenon in three patients with acquired immune deficiency syndrome-related Kaposi sarcoma treated with bleomycin.
    von Gunten CF; Roth EL; Von Roenn JH
    Cancer; 1993 Sep; 72(6):2004-6. PubMed ID: 7689922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
    Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
    Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
    Boudreaux AA; Smith LL; Cosby CD; Bason MM; Tappero JW; Berger TG
    J Am Acad Dermatol; 1993 Jan; 28(1):61-5. PubMed ID: 8381146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of oral Kaposi's sarcoma and a proposal for clinical staging.
    Epstein JB
    Oral Dis; 1997 May; 3 Suppl 1():S124-8. PubMed ID: 9456673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary intraosseous Kaposi's sarcoma of the maxilla in human immunodeficiency virus infection: review of literature and report of case.
    Nichols CM; Flaitz CM; Hicks MJ
    J Oral Maxillofac Surg; 1995 Mar; 53(3):325-9. PubMed ID: 7532218
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence of activity of vinorelbine in patients with previously treated AIDS-associated Kaposi's sarcoma.
    Errante D; Fasan M; Rizzardini G; Landonio G; Pagani L; Zeroli C; Tirelli U
    AIDS; 1996 Dec; 10(14):1742-3. PubMed ID: 8970700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.